002019.SZ
亿帆医药
SZSE · Healthcare · C 制造业 · CN
CNY 9.84
−2.86%Margins
Gross margin
46.7%
EBITDA margin
15.4%
EBIT margin
7.7%
Net margin
7.0%
FCF margin
-2.0%
4.0%
Return on equity
2.8%
Return on assets
3.6%
Return on invested capital
0.39x
Asset turnover
CNY 560.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026